<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biosci Microbiota Food Health</journal-id><journal-id journal-id-type="iso-abbrev">Biosci Microbiota Food Health</journal-id><journal-id journal-id-type="publisher-id">BMFH</journal-id><journal-title-group><journal-title>Bioscience of Microbiota, Food and Health</journal-title></journal-title-group><issn pub-type="ppub">2186-6953</issn><issn pub-type="epub">2186-3342</issn><publisher><publisher-name>BMFH Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27200261</article-id><article-id pub-id-type="pmc">4858881</article-id><article-id pub-id-type="publisher-id">2015-017</article-id><article-id pub-id-type="doi">10.12938/bmfh.2015-017</article-id><article-categories><subj-group subj-group-type="heading"><subject>Full Paper</subject></subj-group></article-categories><title-group><article-title>Perioperative supplementation with bifidobacteria improves postoperative nutritional recovery,
inflammatory response, and fecal microbiota in patients undergoing colorectal surgery: a prospective,
randomized clinical trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>MIZUTA</surname><given-names>Minoru</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>ENDO</surname><given-names>Izuru</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>YAMAMOTO</surname><given-names>Sumiharu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>INOKAWA</surname><given-names>Hidetoshi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>KUBO</surname><given-names>Masatoshi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>UDAKA</surname><given-names>Tetsunobu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>SOGABE</surname><given-names>Osanori</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>MAEDA</surname><given-names>Hiroya</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>SHIRAKAWA</surname><given-names>Kazutoyo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>OKAZAKI</surname><given-names>Eriko</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>ODAMAKI</surname><given-names>Toshitaka</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>ABE</surname><given-names>Fumiaki</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>XIAO</surname><given-names>Jin-zhong</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref rid="cor1" ref-type="corresp"><sup>*</sup></xref></contrib><aff id="aff1"><label>1</label>Mitoyo General Hospital, Takamatsu, Kagawa 769-1695, Japan</aff><aff id="aff2"><label>2</label>Clinico Co., Ltd., Tokyo 153-0063, Japan</aff><aff id="aff3"><label>3</label>Next Generation Science Institute, Morinaga Milk Industry Co., Ltd., 5-1-83
Higashihara, Zama City, Kanagawa 252-8583, Japan</aff><aff id="aff4"><label>4</label>Food Ingredients and Technology Institute, Morinaga Milk Industry Co., Ltd.,
5-1-83 Higashihara, Zama City, Kanagawa 252-8583, Japan</aff></contrib-group><author-notes><corresp id="cor1">*Corresponding author. Mailing address: Jin-zhong Xiao, Next Generation Science Institute,
Morinaga Milk Industry Co., Ltd., 5-1-83 Higashihara, Zama City, Kanagawa 252-8583, Japan. Phone:
+81-46-252-3074, Fax: +81-46-252-3077. E-mail: <email xlink:href="j_xiao@morinagamilk.co.jp">j_xiao@morinagamilk.co.jp</email></corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>12</month><year>2015</year></pub-date><pub-date pub-type="ppub"><year>2016</year></pub-date><volume>35</volume><issue>2</issue><fpage>77</fpage><lpage>87</lpage><history><date date-type="received"><day>10</day><month>8</month><year>2015</year></date><date date-type="accepted"><day>09</day><month>11</month><year>2015</year></date></history><permissions><copyright-statement>BMFH Press</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution
Non-Commercial No Derivatives (by-nc-nd) License. </license-p></license></permissions><abstract><p>The use of probiotics has been widely documented to benefit human health, but their clinical value in
surgical patients remains unclear. The present study investigated the effect of perioperative oral
administration of probiotic bifidobacteria to patients undergoing colorectal surgery. Sixty patients
undergoing colorectal resection were randomized to two groups prior to resection. One group (n=31) received a
probiotic supplement, <italic>Bifidobacterium longum</italic> BB536, preoperatively for 7&#x02013;14 days and
postoperatively for 14 days, while the other group (n=29) received no intervention as a control. The
occurrences of postoperative infectious complications were recorded. Blood and fecal samples were collected
before and after surgery. No significant difference was found in the incidence of postoperative infectious
complications and duration of hospital stay between the two groups. In comparison to the control group, the
probiotic group tended to have higher postoperative levels of erythrocytes, hemoglobin, lymphocytes, total
protein, and albumin and lower levels of high sensitive C-reactive proteins. Postoperatively, the proportions
of fecal bacteria changed significantly; Actinobacteria increased in the probiotic group, Bacteroidetes and
Proteobacteria increased in the control group, and Firmicutes decreased in both groups. Significant
correlations were found between the proportions of fecal bacteria and blood parameters; Actinobacteria
correlated negatively with blood inflammatory parameters, while Bacteroidetes and Proteobacteria correlated
positively with blood inflammatory parameters. In the subgroup of patients who received preoperative
chemoradiotherapy treatment, the duration of hospital stay was significantly shortened upon probiotic
intervention. These results suggest that perioperative oral administration of bifidobacteria may contribute to
a balanced intestinal microbiota and attenuated postoperative inflammatory responses, which may subsequently
promote a healthy recovery after colorectal resection.</p></abstract><kwd-group><kwd>probiotics</kwd><kwd><italic>Bifidobacterium</italic></kwd><kwd>colorectal surgery</kwd><kwd>postoperative complications</kwd><kwd>microbiota</kwd><kwd>nutrition</kwd><kwd>inflammation</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>Probiotics are defined as &#x0201c;live microorganisms which when administered in adequate amounts confer a health
benefit on the host&#x0201d; [<xref rid="r1" ref-type="bibr">1</xref>]. Bifidobacteria and lactic acid bacteria are the
main genera of probiotic microorganisms. Probiotics are widely documented for their roles in prevention and
treatment of diseases, primarily via improving the intestinal environment and enhancing host defense functions
[<xref rid="r2" ref-type="bibr">2</xref>, <xref rid="r3" ref-type="bibr">3</xref>]. Clinical trials have
illustrated that prophylactic administration of probiotics, and in some cases together with prebiotics (as
synbiotics), to patients undergoing abdominal surgery reduced postoperative infections [<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref>]. Systematic reviews and
meta-analyses showed that the use of pro-/synbiotics has positively affected clinical outcomes after abdominal
surgery [<xref rid="r9" ref-type="bibr">9</xref>, <xref rid="r10" ref-type="bibr">10</xref>]. However, another
study demonstrated that the effect of prophylactic administration of probiotics to patients undergoing different
types of gastrointestinal surgeries was insignificant [<xref rid="r11" ref-type="bibr">11</xref>]. The effects
of pro-/synbiotics on postoperative infections in colorectal cancer patients remain controversial, and studies
involving specific strains of probiotics for specific groups of patients are needed to better justify their
efficacy.</p><p>The present study investigated the effect of a probiotic strain, <italic>Bifidobacterium longum</italic> BB536,
which has been reported to have various physiological effects [<xref rid="r12" ref-type="bibr">12</xref>, <xref rid="r13" ref-type="bibr">13</xref>], on immune functions, systemic inflammatory responses, and postoperative
infectious complications in patients undergoing colorectal surgery. Fecal microbial profiling was also performed
to better understand the possible roles of microbiota on health conditions of patients and to justify the
positive outcomes of probiotic intervention.</p></sec><sec sec-type="methods" id="s2"><title>MATERIALS AND METHODS</title><sec><title>Study design and participants</title><p>Patients who had colorectal cancer at 20&#x02013;85 years of age and were scheduled to undergo colorectal cancer
resection at Mitoyo General Hospital between October 2008 and December 2012 were enrolled in this study. The
exclusion criteria were severe diseases of the liver, kidney, heart, and lung and the presence of a food
allergy. Patients with bowel obstruction were also excluded. Written informed consent for participation was
obtained from each patient before enrollment. All study protocols were reviewed and approved by the Local
Ethics Committee of Mitoyo General Hospital, Takamatsu, Japan, and complied with the Helsinki Declaration as
revised in 1983. A flow diagram of participants is shown in <xref ref-type="fig" rid="fig_001">Fig.
1</xref><fig orientation="portrait" fig-type="figure" id="fig_001" position="float"><label>Fig. 1.</label><caption><p>Flow diagram for the study.</p></caption><graphic xlink:href="bmfh-35-077-g001"/></fig>.</p><p>This was a randomized, single-center, single-blinded trial. Physicians involved with the diagnosis of
infections and researchers performing the statistical analyses were not involved in the randomization process.
The subjects were randomized before surgery to either the probiotic group or control group using a
computer-generated permuted-block randomization. Subjects in the probiotic group received a sachet containing
2 g of <italic>B. longum</italic> BB536 powder (approximately 5 &#x000d7; 10<sup>10</sup> colony-forming units/2 g)
daily for 7&#x02013;14 days preoperatively and 14 days postoperatively (starting one day after surgery). The subjects
were advised to ingest this powder by drinking it with milk or water. Subjects who did not receive the
intervention were used as a control group.</p></sec><sec><title>Clinical observation and blood analyses</title><p>All patients started fasting one day before surgery and underwent preoperative bowel preparation by orally
taking an electrolyte-compounding agent (2 L, Niflec, Ajinomoto Pharmaceuticals). All patients received
antibiotic prophylaxis (cefmetazole) as a single intravenous drip infusion on the day of surgery and one day
after surgery. An additional postoperative antibiotic was prescribed when recommended by the physicians who
diagnosed the patients. Detailed daily records of each patient&#x02019;s postoperative course were kept, and
infectious complications were recorded for 14 days after surgery in accordance with the Guideline for the
Prevention of Surgical Site Infection (1999) [<xref rid="r14" ref-type="bibr">14</xref>].</p><p>Blood samples were collected before and after surgery (days: &#x02013;14, 1, 4, 7, and 14) to assess biomarkers
related to the health condition of the patients, with the exception of natural killer (NK) cell activity and
interleukin (IL)-6, which were assessed on days &#x02013;14, 1, and 7. NK cell activity (%) was measured by a
<sup>51</sup>Cr-release assay [<xref rid="r15" ref-type="bibr">15</xref>]. All measurements were performed
by SRL, Inc. (Tokyo, Japan).</p></sec><sec><title>Analysis of fecal microbiota</title><p>Fecal samples were collected from each subject before probiotic ingestion at prior to surgery, and 1 week
after surgery using a sampling kit (Techno Suruga Laboratory Co., Ltd., Shizuoka, Japan), which enabled quick
stabilization of DNA and processing of samples at normal room temperature. Six patients failed to provide
samples before or after surgery; a total of 54 full sets of samples were collected (28 in the probiotic group
and 26 in the control group).</p><p>DNA was extracted from the fecal samples as previously described [<xref rid="r16" ref-type="bibr">16</xref>]
with some modifications. Fifty microliters of 10% sodium dodecyl sulfate, 500 &#x000b5;l of phenol-chloroform, and 300
mg of glass beads (diameter, 0.1 mm) were added to 450 &#x000b5;l of fecal suspension. The mixture was vigorously
vortexed at 2,700 rpm for 3 minutes at 4&#x000b0;C using a Multi-beads shocker (MBS01(S), Yasui Kikai Corporation,
Osaka, Japan). After centrifugation at 14,000&#x000d7;<italic>g</italic> for 5 min, 400 &#x000b5;l of supernatant was
extracted with phenol-chloroform, and 250 &#x000b5;l of the supernatant was precipitated with isopropanol. Inhibitors
were removed using a High Pure PCR Template Preparation Kit (Roche). The purified DNA was suspended in 200 &#x000b5;l
of Tris-EDTA buffer (pH 8.0).</p><p>The V3-V4 region of bacterial 16S rRNA genes was amplified by PCR with a TaKaRa Ex Taq HS kit (TaKaRa Bio,
Shiga, Japan) and the primer set of Tru357F (5&#x02032;-CGCTCTTCCGATCTCTG TACGGRAGGCAGCAG-3&#x02032;) and Tru806R
(5&#x02032;-CGCTCTTCCGATCTGAC GGACTACHVGGGTWTCTAAT-3&#x02032;). DNA was amplified according to the following program:
preheating at 94&#x000b0;C for 3 min; 25 cycles of denaturation at 94&#x000b0;C for 30 sec, annealing at 50&#x000b0;C for 30 sec, and
extension at 72&#x000b0;C for 30 sec; and a final terminal extension at 72&#x000b0;C for 10 min. Upon checking the size and
the quantity of the ampli&#x0fb01;ed DNA using a QIAxcel system (Qiagen, Valencia, CA, USA), 1 &#x000b5;l of the PCR products
were amplified with a 2nd primer set, adapted for the Illumina MiSeq. DNA was amplified using the same program
as described above, except that a 15 amplification cycles were used instead of 25. After checking the size and
the quantity of the 2nd set of ampli&#x0fb01;ed DNA products using the QIAxcel system, the products were purified
using a QIAquick 96 PCR Purification Kit (Qiagen, Valencia, CA, USA) according to the manufacturer&#x02019;s protocol.
The purified products were quantified using a Quant-iT PicoGreend dsDNA Assay kit (Life Technologies,
Carlsbad, CA, USA). Subsequently, equal amounts of the amplicons from different samples were pooled, and
primer-dimers were removed by gel extraction with a QIAquick PCR Purification Kit. The pooled libraries were
sequenced using an Illumina Miseq instrument with a MiSeq v2 Reagent kit.</p><p>The Illumina paired-end reads that passed the quality filters were combined by the fastq-join script in
EA-Utils (ver. 1.1.2-537) [<xref rid="r17" ref-type="bibr">17</xref>]. The sequences were then analyzed using
the QIIME software package version 1.6.0 [<xref rid="r18" ref-type="bibr">18</xref>, <xref rid="r19" ref-type="bibr">19</xref>] (http://quime.org/). Potential chimeric sequences were removed using UCHIME, assigned
to operational taxonomic units (OTUs) using open-reference OTU picking [<xref rid="r20" ref-type="bibr">20</xref>] with a 97% threshold of pairwise identity, and then classified taxonomically using the
Greengenes reference database (<ext-link ext-link-type="uri" xlink:href="http://greengenes.secondgenome.com/downloads/database/12_10">http://greengenes.secondgenome.com/downloads/database/12_10</ext-link>) and a confidence
threshold of 60% [<xref rid="r21" ref-type="bibr">21</xref>]. As a result, 1,363,590 sequences were assigned
to 108 samples, in which the average &#x000b1; standard deviation of the read number per sample was 12,625 &#x000b1; 3,370.
UniFrac distances were calculated from the Illumina V3-4 16S rRNA gene dataset.</p></sec><sec><title>Statistical analyses</title><p>Postoperative infectious complication was predetermined as the primary efficacy variable. The secondary
variables were as follows: additional postoperative antibiotic treatment, hospital stay, and changes in blood
parameters and the microbiota. Regarding sample size, a minimum of 60 subjects were required to demonstrate a
reduction in postoperative infectious complications from 40% to 15% at a 5% significant level with 80% power,
similar to that seen in another study [<xref rid="r22" ref-type="bibr">22</xref>].</p><p>Results of blood parameters are expressed as the mean &#x000b1; SD or SE. Statistical analyses were performed using
the paired and unpaired Student&#x02019;s t-test for continuous variables and Fisher&#x02019;s exact test for categorical
variables in comparison between the control and probiotic groups. Variables that did not follow a normal
distribution were analyzed after natural log transformation. The data for the microbiota were expressed as the
median and interquartile range (IQR) of the proportion of each bacterial category in the microbiota, and the
within-group difference and between-group difference at each time point were analyzed using the Wilcoxon
signed-rank test and Mann-Whitney U-test, respectively. Statistical significance was determined at
p&#x0003c;0.05.</p></sec></sec><sec sec-type="results" id="s3"><title>RESULTS</title><sec><title>Demographics of patients and clinical observation</title><p>A total of 60 patients, 31 in the probiotic group and 29 in the control group, were enrolled. The baseline
characteristics of the probiotic and control groups are shown in <xref rid="tbl_001" ref-type="table">Table
1</xref><table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Background characteristics for all patients and those patients who received preoperative
chemoradiotherapy (CRT)</title></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="3" rowspan="2" valign="bottom" align="left"/><th colspan="2" valign="bottom" align="center" rowspan="1">All patients<sup>&#x02020;</sup>
<hr/></th><th colspan="2" valign="bottom" align="center" rowspan="1">CRT patients<sup>&#x02020;</sup>
<hr/></th></tr><tr><th valign="bottom" align="center" rowspan="1" colspan="1">Control (n=29)</th><th valign="bottom" align="center" rowspan="1" colspan="1">Probiotic (n=31)</th><th valign="bottom" align="center" rowspan="1" colspan="1">Control (n=7)</th><th valign="bottom" align="center" rowspan="1" colspan="1">Probiotic (n=8)</th></tr></thead><tbody><tr><td align="left" valign="top" colspan="3" rowspan="1">Gender (Male/Female)</td><td align="center" valign="top" rowspan="1" colspan="1"> 15/14</td><td align="center" valign="top" rowspan="1" colspan="1"> 20/11</td><td align="center" valign="top" rowspan="1" colspan="1"> 6/1</td><td align="center" valign="top" rowspan="1" colspan="1"> 7/1</td></tr><tr><td align="left" valign="top" colspan="3" rowspan="1">Age (years)</td><td align="center" valign="top" rowspan="1" colspan="1">71.2 &#x000b1; 9.5</td><td align="center" valign="top" rowspan="1" colspan="1">68.9 &#x000b1; 10.4</td><td align="center" valign="top" rowspan="1" colspan="1">71.3 &#x000b1; 8.8</td><td align="center" valign="top" rowspan="1" colspan="1">65.9 &#x000b1; 8.2</td></tr><tr><td align="left" valign="top" colspan="3" rowspan="1">Body mass index (BMI)</td><td align="center" valign="top" rowspan="1" colspan="1">24.1 &#x000b1; 3.4</td><td align="center" valign="top" rowspan="1" colspan="1">22.4 &#x000b1; 3.7</td><td align="center" valign="top" rowspan="1" colspan="1">24.0 &#x000b1; 2.6</td><td align="center" valign="top" rowspan="1" colspan="1">21.3 &#x000b1; 3</td></tr><tr><td align="left" valign="top" colspan="3" rowspan="1">Preoperative chemoradiotherapy (CRT)</td><td align="center" valign="top" rowspan="1" colspan="1">7 (24.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (25.8%)</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td></tr><tr><td align="left" valign="top" colspan="3" rowspan="1">Preoperative diabetes </td><td align="center" valign="top" rowspan="1" colspan="1">6 (20.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">6 (19.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" colspan="3" rowspan="1">Preoperative complication</td><td align="center" valign="top" rowspan="1" colspan="1">5 (17.2%)</td><td align="center" valign="top" rowspan="1" colspan="1">7 (22.6%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (28.6%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (25.0%)</td></tr><tr><td align="left" valign="top" colspan="3" rowspan="1">Operation time (min)</td><td align="center" valign="top" rowspan="1" colspan="1">230.0 &#x000b1; 84.4</td><td align="center" valign="top" rowspan="1" colspan="1">218.9 &#x000b1; 88.7</td><td align="center" valign="top" rowspan="1" colspan="1">305.9 &#x000b1; 110.4</td><td align="center" valign="top" rowspan="1" colspan="1">281.0 &#x000b1; 121.3</td></tr><tr><td align="left" valign="top" colspan="7" rowspan="1">Types of surgery </td></tr><tr><td align="left" valign="top" rowspan="3" colspan="2"/><td align="left" valign="top" rowspan="1" colspan="1"> Colon</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Rectum</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Others</td><td align="center" valign="top" rowspan="1" colspan="1">4<sup>&#x02021;</sup></td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">1<sup>&#x000a7;</sup></td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" colspan="7" rowspan="1">Blood parameters before surgery (D&#x02013;14)</td></tr><tr><td align="left" valign="top" rowspan="10" colspan="1"/><td align="left" valign="top" colspan="2" rowspan="1">White blood cells (/&#x000b5;l)</td><td align="center" valign="top" rowspan="1" colspan="1">5,603 &#x000b1; 1,910</td><td align="center" valign="top" rowspan="1" colspan="1">5,446 &#x000b1; 1,559</td><td align="center" valign="top" rowspan="1" colspan="1">4,570 &#x000b1; 968</td><td align="center" valign="top" rowspan="1" colspan="1">4,950 &#x000b1; 1,331</td></tr><tr><td align="left" valign="top" colspan="2" rowspan="1">Erythrocytes (10<sup>4</sup> /&#x000b5;l)</td><td align="center" valign="top" rowspan="1" colspan="1">433 &#x000b1; 46</td><td align="center" valign="top" rowspan="1" colspan="1">417 &#x000b1; 42</td><td align="center" valign="top" rowspan="1" colspan="1">438.4 &#x000b1; 51.8</td><td align="center" valign="top" rowspan="1" colspan="1">413.9 &#x000b1; 32.2</td></tr><tr><td align="left" valign="top" colspan="2" rowspan="1">Hemoglobin (g/dl)</td><td align="center" valign="top" rowspan="1" colspan="1">12.3 &#x000b1; 1.8</td><td align="center" valign="top" rowspan="1" colspan="1">12.4 &#x000b1; 2.1</td><td align="center" valign="top" rowspan="1" colspan="1">13.2 &#x000b1; 1.8</td><td align="center" valign="top" rowspan="1" colspan="1">1 &#x000b1; 1.4</td></tr><tr><td align="left" valign="top" colspan="2" rowspan="1">Lymphocytes (%)</td><td align="center" valign="top" rowspan="1" colspan="1">27.8 &#x000b1; 8.5</td><td align="center" valign="top" rowspan="1" colspan="1">24.4 &#x000b1; 10.3</td><td align="center" valign="top" rowspan="1" colspan="1">18.3 &#x000b1; 4.2</td><td align="center" valign="top" rowspan="1" colspan="1">27.3 &#x000b1; 9.2**</td></tr><tr><td align="left" valign="top" colspan="2" rowspan="1">Platelet (10<sup>4</sup> /&#x000b5;l)</td><td align="center" valign="top" rowspan="1" colspan="1">22.8 &#x000b1; 9.5</td><td align="center" valign="top" rowspan="1" colspan="1">26.6 &#x000b1; 10.2</td><td align="center" valign="top" rowspan="1" colspan="1">20.0 &#x000b1; 6.6</td><td align="center" valign="top" rowspan="1" colspan="1">19.6 &#x000b1; 9.1</td></tr><tr><td align="left" valign="top" colspan="2" rowspan="1">Total protein (g/dl)</td><td align="center" valign="top" rowspan="1" colspan="1">7.0 &#x000b1; 0.6</td><td align="center" valign="top" rowspan="1" colspan="1">6.8 &#x000b1; 0.7</td><td align="center" valign="top" rowspan="1" colspan="1">6.8 &#x000b1; 0.7</td><td align="center" valign="top" rowspan="1" colspan="1">6.4 &#x000b1; 0.9</td></tr><tr><td align="left" valign="top" colspan="2" rowspan="1">Albumin (g/dl)</td><td align="center" valign="top" rowspan="1" colspan="1">4.0 &#x000b1; 0.4</td><td align="center" valign="top" rowspan="1" colspan="1">3.8 &#x000b1; 0.6</td><td align="center" valign="top" rowspan="1" colspan="1">4.0 &#x000b1; 0.4</td><td align="center" valign="top" rowspan="1" colspan="1">3.5 &#x000b1; 0.7*</td></tr><tr><td align="left" valign="top" colspan="2" rowspan="1">hCRP (mg/dl)</td><td align="center" valign="top" rowspan="1" colspan="1">0.5 &#x000b1; 1.5</td><td align="center" valign="top" rowspan="1" colspan="1">0.5 &#x000b1; 0.6</td><td align="center" valign="top" rowspan="1" colspan="1">0.2 &#x000b1; 0.1</td><td align="center" valign="top" rowspan="1" colspan="1">0.4 &#x000b1; 0.3</td></tr><tr><td align="left" valign="top" colspan="2" rowspan="1">IL-6 (pg/ml)</td><td align="center" valign="top" rowspan="1" colspan="1">6.0 &#x000b1; 9.1</td><td align="center" valign="top" rowspan="1" colspan="1">6.6 &#x000b1; 10.2</td><td align="center" valign="top" rowspan="1" colspan="1">3.5 &#x000b1; 1.7</td><td align="center" valign="top" rowspan="1" colspan="1">11.1 &#x000b1; 18.8</td></tr><tr><td align="left" valign="top" colspan="2" rowspan="1">NK cell activity (%)</td><td align="center" valign="top" rowspan="1" colspan="1">40.3 &#x000b1; 18.1</td><td align="center" valign="top" rowspan="1" colspan="1">43.8 &#x000b1; 13.6</td><td align="center" valign="top" rowspan="1" colspan="1">40.0 &#x000b1; 14.4</td><td align="center" valign="top" rowspan="1" colspan="1">42.6 &#x000b1; 15.4</td></tr></tbody></table><table-wrap-foot><p><sup>&#x02020;</sup>Groups were compared using Student&#x02019;s t-test for continuous variables and Fisher&#x02019;s exact
test for categorical variables. *p&#x0003c;0.05, **p&#x0003c;0.01. <sup>&#x02021;</sup>Anal canal cancer (n=1),
postoperative local recurrence of rectum cancer (n=1), rectovaginal fistula (n=1), colostomy (n=1).
<sup>&#x000a7;</sup>Anal canal cancer.</p></table-wrap-foot></table-wrap>. No significant differences in sex, age, BMI, types of surgery, and length of operation were
found between the two groups (<xref rid="tbl_001" ref-type="table">Table 1</xref>). In addition, no
significant differences were found in the numbers of subjects with preoperative diabetes and preoperative
complications. The probiotic group included 11 colon and 19 rectal cancer patients, whereas the control group
included 12 patients with colon cancer, 13 patients with rectal cancer, 1 patients with anal canal cancer, 1
patients with local postoperative recurrence of rectal cancer, 1 patients with rectovaginal fistula, and 1
colostomy patient. The study groups did not differ significantly in preoperative values of blood
parameters.</p><p>Among the patients with rectal and anal canal cancer, 8 in the probiotic group and 7 in the control group
received preoperative chemoradiotherapy (CRT). The CRT was performed by oral administration of 5-FU/l-LV for 7
to 9 weeks accompanied by irradiation treatment (3 Gy per day, up to a total of 45 Gy). Surgery was performed
6 to 8 weeks after the CRT. The study groups did not differ significantly in preoperative values of blood
parameters with the exception of lymphocytes and albumin. Among the CRT patients, a significantly higher level
of lymphocytes (p&#x0003c;0.01) and lower level of albumin (p&#x0003c;0.05) were observed in the probiotic group
compared with the control group (<xref rid="tbl_001" ref-type="table">Table 1</xref>).</p><p>The rates of postoperative infections did not differ significantly between the probiotic and control groups
(p&#x0003e;0.1); 16.1% and 24.1% for superficial surgical site infections (SSI), 6.5% and 10.3% for deep SSI, and
9.7% and 17.2% for anastomotic leakage, respectively, for the probiotic and control groups. Insignificant
differences (p&#x0003e;0.1) were also observed in the frequency of additional postoperative antibiotic treatment
and duration of hospital stay between the two groups (<xref rid="tbl_002" ref-type="table">Table
2</xref><table-wrap id="tbl_002" orientation="portrait" position="float"><label>Table 2.</label><caption><title>Clinical observations for all patients and those patients who received preoperative
chemoradiotherapy (CRT)</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="bottom" align="left" colspan="1"/><th colspan="2" valign="bottom" align="center" rowspan="1">All patients<sup>&#x02020;</sup>
<hr/></th><th colspan="2" valign="bottom" align="center" rowspan="1">CRT patients<sup>&#x02020;</sup>
<hr/></th></tr><tr><th valign="bottom" align="center" rowspan="1" colspan="1">Control (n=29)</th><th valign="bottom" align="center" rowspan="1" colspan="1">Probiotic (n=31)</th><th valign="bottom" align="center" rowspan="1" colspan="1">Control (n=7)</th><th valign="bottom" align="center" rowspan="1" colspan="1">Probiotic (n=8)</th></tr></thead><tbody><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Hospital stay (day)</td><td align="center" valign="bottom" rowspan="1" colspan="1">23.0 &#x000b1; 13.8</td><td align="center" valign="bottom" rowspan="1" colspan="1">21.4 &#x000b1; 10.1</td><td align="center" valign="bottom" rowspan="1" colspan="1">39.6 &#x000b1; 15.6</td><td align="center" valign="bottom" rowspan="1" colspan="1">21.6 &#x000b1; 11.7 *</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Surficial infection</td><td align="center" valign="bottom" rowspan="1" colspan="1">7 (24.1%)</td><td align="center" valign="bottom" rowspan="1" colspan="1">5 (16.1%)</td><td align="center" valign="bottom" rowspan="1" colspan="1">4 (57.1%)</td><td align="center" valign="bottom" rowspan="1" colspan="1">3 (37.5%)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Deep infection</td><td align="center" valign="bottom" rowspan="1" colspan="1">3 (10.3%)</td><td align="center" valign="bottom" rowspan="1" colspan="1">2 (6.5%)</td><td align="center" valign="bottom" rowspan="1" colspan="1">3 (42.9%)</td><td align="center" valign="bottom" rowspan="1" colspan="1">2 (25.0%)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Anastomotic leak</td><td align="center" valign="bottom" rowspan="1" colspan="1">5 (17.2%)</td><td align="center" valign="bottom" rowspan="1" colspan="1">3 (9.7%)</td><td align="center" valign="bottom" rowspan="1" colspan="1">4 (57.1%)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Additional antibiotic treatment</td><td align="center" valign="bottom" rowspan="1" colspan="1">7 (24.1%)</td><td align="center" valign="bottom" rowspan="1" colspan="1">8 (25.8%)</td><td align="center" valign="bottom" rowspan="1" colspan="1">5 (71.4%)</td><td align="center" valign="bottom" rowspan="1" colspan="1">3 (37.5%)</td></tr></tbody></table><table-wrap-foot><p><sup>&#x02020;</sup>Groups were compared using Student&#x02019;s t-test for continuous variables and Fisher&#x02019;s exact
test for categorical variables. *p&#x0003c;0.05.</p></table-wrap-foot></table-wrap>).</p><p>The occurrences of postoperative infections in patients who received preoperative CRT treatment were higher
than those without CRT treatment (<xref rid="tbl_002" ref-type="table">Table 2</xref>). Four patients in the
control group but none in the probiotic group experienced postoperative anastomotic leakage (p=0.10, probiotic
vs control). In addition, the duration of hospital stay was significantly shortened in the probiotic group
(39.6 &#x000b1; 15.6 days, p=0.03) compared with the control group (21.6 &#x000b1; 11.7 days).</p></sec><sec><title>Changes in blood parameters</title><p>The blood parameters changed significantly after surgery in both the control and the probiotic groups (<xref ref-type="fig" rid="fig_002">Fig. 2</xref><fig orientation="portrait" fig-type="figure" id="fig_002" position="float"><label>Fig. 2.</label><caption><p>Changes in blood parameters during the trial period for patients who underwent colorectal surgery.</p><p>Changes in values, compared with D&#x02013;14, are shown as means &#x000b1; SE. &#x025cb;, control group; &#x025cf;, probiotic group.
*p&#x0003c;0.05, **p&#x0003c;0.01, paired t-test with Bonferroni correction for within-group differences from
baseline (D&#x02013;14). <sup>&#x02020;</sup>p&#x0003c;0.1, <sup>&#x02021;</sup>p&#x0003c;0.05; Student&#x02019;s t-test for between-group
differences at each time point. (A) white blood cell; (B) erythrocytes; (C) hemoglobin; (D) lymphocytes;
(E) platelets; (F) total protein; (G)albumin; (H) high sensitive C-reactive protein; (I) interleukin-6;
(J) natural killer cell activity.</p></caption><graphic xlink:href="bmfh-35-077-g002"/></fig>). There were significant increases in white blood cells and high-sensitive C-reactive protein (hCRP)
and significant decreases in erythrocytes, hemoglobin, lymphocytes, total protein, albumin, and NK cell
activity after surgery (D1) in the control and probiotic groups (<xref ref-type="fig" rid="fig_002">Fig.
2</xref>). Significant between-group differences were found in the changes from preoperative levels (D&#x02013;14)
of erythrocytes (D14), total protein (D1), and albumin (D1 and D7). Tendencies for differences (p&#x0003c;0.1) were
also found in the changes from baseline values (D&#x02013;14) of hemoglobin (D14), lymphocytes (D1), and hCRP (D14)
between the two groups (<xref ref-type="fig" rid="fig_002">Fig. 2</xref>).</p><p>Among those patients who received CRT treatment, similar within-group changes and between-group differences
as found in the whole groups were observed (<xref ref-type="fig" rid="fig_003">Fig. 3</xref><fig orientation="portrait" fig-type="figure" id="fig_003" position="float"><label>Fig. 3.</label><caption><p>Changes in blood parameters during the trial period among patients who received preoperative
chemoradiotherapy.</p><p>Changes in values, compared with D&#x02013;14, are shown as means &#x000b1; SE. &#x025cb;, control group; &#x025cf;, probiotic group.
*p&#x0003c;0.05, **p&#x0003c;0.01, paired t-test with Bonferroni correction for within-group differences from
baseline (D&#x02013;14). <sup>&#x02020;</sup>p&#x0003c;0.1, <sup>&#x02021;</sup>p&#x0003c;0.05, <sup>#</sup>p&#x0003c;0.01, Student&#x02019;s t-test
for between-group differences at each time point. (A) white blood cell; (B) erythrocytes; (C)
hemoglobin; (D) lymphocytes; (E) platelets; (F) total protein; (G) albumin; (H) high-sensitive
C-reactive protein; (I) interleukin-6; (J) natural killer cell activity.</p></caption><graphic xlink:href="bmfh-35-077-g003"/></fig>). In particular, the levels of hCRP remained high at two weeks after surgery in the control group, but
declined to near preoperative levels in the probiotic group (<xref ref-type="fig" rid="fig_003">Fig.
3</xref>). In addition, 7 days after surgery, NK cell activity recovered to near preoperative levels in the
probiotic group, but remained low in the control group (<xref ref-type="fig" rid="fig_003">Fig. 3</xref>).
Significant between-group differences were found in the changes from preoperative levels (D&#x02013;14) of white blood
cells (D14), erythrocytes (D14), and hCRP (D7 and D14). Tendencies of differences (p&#x0003c;0.1) were also found
in the changes from baseline values (D&#x02013;14) of white blood cells (D1), hemoglobin (D14), and total protein
(D14) between the two groups (<xref ref-type="fig" rid="fig_003">Fig. 3</xref>).</p></sec><sec><title>Changes in fecal microbiota</title><p>High-throughput sequencing analysis of the fecal microbiota at the phylum level indicated significant
postoperative increases in the proportion of Bacteroidetes and Proteobacteria, but significant decreases in
those of Firmicutes and unclassified bacterial groups in the control group (<xref rid="tbl_003" ref-type="table">Table 3</xref><table-wrap id="tbl_003" orientation="portrait" position="float"><label>Table 3.</label><caption><title>The proportions of bacterial phyla in the fecal microbiota</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" align="center" colspan="1">Category at phylum level</th><th colspan="4" align="center" rowspan="1">Control group<hr/></th><th colspan="4" align="center" rowspan="1">BB536 group<hr/></th></tr><tr><th colspan="2" align="center" rowspan="1">Before surgery</th><th colspan="2" align="center" rowspan="1">After surgery</th><th colspan="2" align="center" rowspan="1">Before surgery</th><th colspan="2" align="center" rowspan="1">After surgery</th></tr><tr><th align="center" rowspan="1" colspan="1">median (%)</th><th align="center" rowspan="1" colspan="1">IQR (%)</th><th align="center" rowspan="1" colspan="1">median (%)</th><th align="center" rowspan="1" colspan="1">IQR (%)</th><th align="center" rowspan="1" colspan="1">median (%)</th><th align="center" rowspan="1" colspan="1">IQR (%)</th><th align="center" rowspan="1" colspan="1">median (%)</th><th align="center" rowspan="1" colspan="1">IQR (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Actinobacteria</td><td align="center" rowspan="1" colspan="1">1.95 </td><td align="center" rowspan="1" colspan="1">0.32&#x02013;4.89</td><td align="center" rowspan="1" colspan="1">0.63 </td><td align="center" rowspan="1" colspan="1">0.21&#x02013;2.60</td><td align="center" rowspan="1" colspan="1">0.70 </td><td align="center" rowspan="1" colspan="1">0.24&#x02013;1.90</td><td align="center" rowspan="1" colspan="1">1.71 </td><td align="center" rowspan="1" colspan="1">0.36&#x02013;3.09*</td></tr><tr><td align="left" rowspan="1" colspan="1">Bacteroidetes</td><td align="center" rowspan="1" colspan="1">24.52 </td><td align="center" rowspan="1" colspan="1">18.32&#x02013;32.01</td><td align="center" rowspan="1" colspan="1">32.80 </td><td align="center" rowspan="1" colspan="1">27.17&#x02013;40.60*</td><td align="center" rowspan="1" colspan="1">24.72 </td><td align="center" rowspan="1" colspan="1">18.88&#x02013;32.89</td><td align="center" rowspan="1" colspan="1">29.56 </td><td align="center" rowspan="1" colspan="1">24.76&#x02013;32.87</td></tr><tr><td align="left" rowspan="1" colspan="1">Firmicutes</td><td align="center" rowspan="1" colspan="1">66.57 </td><td align="center" rowspan="1" colspan="1">57.18&#x02013;75.96</td><td align="center" rowspan="1" colspan="1">56.82 </td><td align="center" rowspan="1" colspan="1">46.77&#x02013;64.24*</td><td align="center" rowspan="1" colspan="1">62.31 </td><td align="center" rowspan="1" colspan="1">52.34&#x02013;72.98</td><td align="center" rowspan="1" colspan="1">56.51 </td><td align="center" rowspan="1" colspan="1">48.46&#x02013;64.15*</td></tr><tr><td align="left" rowspan="1" colspan="1">Fusobacteria</td><td align="center" rowspan="1" colspan="1">0.23 </td><td align="center" rowspan="1" colspan="1">0.08&#x02013;1.37</td><td align="center" rowspan="1" colspan="1">0.25 </td><td align="center" rowspan="1" colspan="1">0.07&#x02013;3.76</td><td align="center" rowspan="1" colspan="1">0.18 </td><td align="center" rowspan="1" colspan="1">0.10&#x02013;2.09</td><td align="center" rowspan="1" colspan="1">0.69 </td><td align="center" rowspan="1" colspan="1">0.09&#x02013;2.75</td></tr><tr><td align="left" rowspan="1" colspan="1">Proteobacteria</td><td align="center" rowspan="1" colspan="1">1.74 </td><td align="center" rowspan="1" colspan="1">1.50&#x02013;2.16</td><td align="center" rowspan="1" colspan="1">3.54 </td><td align="center" rowspan="1" colspan="1">2.90&#x02013;5.84*</td><td align="center" rowspan="1" colspan="1">2.05 </td><td align="center" rowspan="1" colspan="1">1.54&#x02013;5.06</td><td align="center" rowspan="1" colspan="1">3.43 </td><td align="center" rowspan="1" colspan="1">2.27&#x02013;9.75</td></tr><tr><td align="left" rowspan="1" colspan="1">Unclassified</td><td align="center" rowspan="1" colspan="1">0.50 </td><td align="center" rowspan="1" colspan="1">0.37&#x02013;0.55</td><td align="center" rowspan="1" colspan="1">0.37 </td><td align="center" rowspan="1" colspan="1">0.26&#x02013;0.51*</td><td align="center" rowspan="1" colspan="1">0.33 </td><td align="center" rowspan="1" colspan="1">0.25&#x02013;0.51</td><td align="center" rowspan="1" colspan="1">0.32 </td><td align="center" rowspan="1" colspan="1">0.21&#x02013;0.46</td></tr></tbody></table><table-wrap-foot><p>The data for the microbiota were expressed as the median and interquartile range (IQR) of the
proportion of each bacterial category. *p&#x0003c;0.05, intra-group difference.</p></table-wrap-foot></table-wrap>). On the other hand, the proportion of Actinobacteria increased and proportion of Firmicutes
decreased significantly in the probiotic group. The proportions of these bacterial groups did not differ
significantly between the two groups at before or after surgery (<xref rid="tbl_003" ref-type="table">Table
3</xref>).</p></sec><sec><title>Correlation between compositions of fecal microbiota with blood parameters</title><p>Taking into consideration the whole samples collected preoperatively and postoperatively, analysis revealed
the following correlations between the proportions of bacterial groups with blood parameters: 1)
Actinobacteria significantly correlated positively with erythrocytes, hemoglobin, albumin, and NK cell
activity; 2) Firmicutes significantly correlated positively with lymphocytes, total protein, and albumin, but
negatively with white blood cells, hCRP, and IL-6; 3) the proportions of Bacteroidetes significantly
correlated negatively with total protein and albumin but positively with hCRP and IL-6; and 4) the proportions
of Proteobacteria significantly correlated negatively with erythrocytes, hemoglobin, lymphocytes, total
protein, and albumin but positively with white blood cells, hCRP and IL-6 (<xref rid="tbl_004" ref-type="table">Table 4</xref><table-wrap id="tbl_004" orientation="portrait" position="float"><label>Table 4.</label><caption><title>Correlations between blood biochemical parameters and the composition of fecal microbiota of all
patients</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" colspan="1">Blood parameters</th><th rowspan="2" align="center" colspan="1">Data analysis</th><th colspan="5" align="center" rowspan="1">Spearman&#x02019;s correlation<hr/></th></tr><tr><th align="center" rowspan="1" colspan="1">Actinobacteria</th><th valign="middle" align="center" rowspan="1" colspan="1">Bacteroidetes</th><th valign="middle" align="center" rowspan="1" colspan="1">Firmicutes</th><th valign="middle" align="center" rowspan="1" colspan="1">Proteobacteria</th><th valign="middle" align="center" rowspan="1" colspan="1">Unclassified</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="3" colspan="1">White blood cells</td><td align="left" valign="top" rowspan="1" colspan="1">Before+after</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.062</td><td align="center" valign="top" rowspan="1" colspan="1">0.127</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.246*</td><td align="center" valign="top" rowspan="1" colspan="1">0.205*</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.114</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Before</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.183</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.013</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.016</td><td align="center" valign="top" rowspan="1" colspan="1">0.037</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.078</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">After</td><td align="center" valign="top" rowspan="1" colspan="1">0.017</td><td align="center" valign="top" rowspan="1" colspan="1">0.048</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.287*</td><td align="center" valign="top" rowspan="1" colspan="1">0.099</td><td align="center" valign="top" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" valign="top" rowspan="3" colspan="1">Erythrocytes</td><td align="left" valign="top" rowspan="1" colspan="1">Before+after</td><td align="center" valign="top" rowspan="1" colspan="1">0.211*</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.095</td><td align="center" valign="top" rowspan="1" colspan="1">0.046</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.308**</td><td align="center" valign="top" rowspan="1" colspan="1">0.06</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Before</td><td align="center" valign="top" rowspan="1" colspan="1">0.204</td><td align="center" valign="top" rowspan="1" colspan="1">0.061</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.206</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.132</td><td align="center" valign="top" rowspan="1" colspan="1">0.105</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">After</td><td align="center" valign="top" rowspan="1" colspan="1">0.312*</td><td align="center" valign="top" rowspan="1" colspan="1">0.082</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.102</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.165</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.158</td></tr><tr><td align="left" valign="top" rowspan="3" colspan="1">Hemoglobin</td><td align="left" valign="top" rowspan="1" colspan="1">Before+after</td><td align="center" valign="top" rowspan="1" colspan="1">0.361**</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.052</td><td align="center" valign="top" rowspan="1" colspan="1">0.032</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.241*</td><td align="center" valign="top" rowspan="1" colspan="1">0.138</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Before</td><td align="center" valign="top" rowspan="1" colspan="1">0.301*</td><td align="center" valign="top" rowspan="1" colspan="1">0.054</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.11</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.045</td><td align="center" valign="top" rowspan="1" colspan="1">0.153</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">After</td><td align="center" valign="top" rowspan="1" colspan="1">0.472**</td><td align="center" valign="top" rowspan="1" colspan="1">0.074</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.141</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.196</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.013</td></tr><tr><td align="left" valign="top" rowspan="3" colspan="1">Lymphocytes</td><td align="left" valign="top" rowspan="1" colspan="1">Before+after</td><td align="center" valign="top" rowspan="1" colspan="1">0.131</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.152</td><td align="center" valign="top" rowspan="1" colspan="1">0.317**</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.322**</td><td align="center" valign="top" rowspan="1" colspan="1">0.189<sup>&#x02020;</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Before</td><td align="center" valign="top" rowspan="1" colspan="1">0.234<sup>&#x02020;</sup></td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.054</td><td align="center" valign="top" rowspan="1" colspan="1">0.037</td><td align="center" valign="top" rowspan="1" colspan="1">0.025</td><td align="center" valign="top" rowspan="1" colspan="1">0.186</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">After</td><td align="center" valign="top" rowspan="1" colspan="1">0.035</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.016</td><td align="center" valign="top" rowspan="1" colspan="1">0.366**</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.282*</td><td align="center" valign="top" rowspan="1" colspan="1">0.034</td></tr><tr><td align="left" valign="top" rowspan="3" colspan="1">Total protein</td><td align="left" valign="top" rowspan="1" colspan="1">Before+after</td><td align="center" valign="top" rowspan="1" colspan="1">0.099</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.267**</td><td align="center" valign="top" rowspan="1" colspan="1">0.311**</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.373**</td><td align="center" valign="top" rowspan="1" colspan="1">0.039</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Before</td><td align="center" valign="top" rowspan="1" colspan="1">0.031</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.131</td><td align="center" valign="top" rowspan="1" colspan="1">0.134</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.094</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.13</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">After</td><td align="center" valign="top" rowspan="1" colspan="1">0.228</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.144</td><td align="center" valign="top" rowspan="1" colspan="1">0.122</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.252<sup>&#x02020;</sup></td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.074</td></tr><tr><td align="left" valign="top" rowspan="3" colspan="1">Albumin</td><td align="left" valign="top" rowspan="1" colspan="1">Before+after</td><td align="center" valign="top" rowspan="1" colspan="1">0.242*</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.240*</td><td align="center" valign="top" rowspan="1" colspan="1">0.311**</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.391**</td><td align="center" valign="top" rowspan="1" colspan="1">0.171<sup>&#x02020;</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Before</td><td align="center" valign="top" rowspan="1" colspan="1">0.383*</td><td align="center" valign="top" rowspan="1" colspan="1">0.083</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.056</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.158</td><td align="center" valign="top" rowspan="1" colspan="1">0.034</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">After</td><td align="center" valign="top" rowspan="1" colspan="1">0.294*</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.194</td><td align="center" valign="top" rowspan="1" colspan="1">0.300*</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.297*</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.022</td></tr><tr><td align="left" valign="top" rowspan="3" colspan="1">hCRP</td><td align="left" valign="top" rowspan="1" colspan="1">Before+after</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.163<sup>&#x02020;</sup></td><td align="center" valign="top" rowspan="1" colspan="1">0.222*</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.263**</td><td align="center" valign="top" rowspan="1" colspan="1">0.398**</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.277**</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Before</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.179</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.02</td><td align="center" valign="top" rowspan="1" colspan="1">0.112</td><td align="center" valign="top" rowspan="1" colspan="1">0.159</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.227<sup>&#x02020;</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">After</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.247<sup>&#x02020;</sup></td><td align="center" valign="top" rowspan="1" colspan="1">0.043</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.203</td><td align="center" valign="top" rowspan="1" colspan="1">0.154</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.173</td></tr><tr><td align="left" valign="top" rowspan="3" colspan="1">IL-6</td><td align="left" valign="top" rowspan="1" colspan="1">Before+after</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.231*</td><td align="center" valign="top" rowspan="1" colspan="1">0.199**</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.204**</td><td align="center" valign="top" rowspan="1" colspan="1">0.327***</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.236*</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Before</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.321*</td><td align="center" valign="top" rowspan="1" colspan="1">0.005</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.136</td><td align="center" valign="top" rowspan="1" colspan="1">0.185</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.13</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">After</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.348*</td><td align="center" valign="top" rowspan="1" colspan="1">0.004</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.184</td><td align="center" valign="top" rowspan="1" colspan="1">0.155</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;0.074</td></tr><tr><td align="left" valign="top" rowspan="3" colspan="1">NK cell activity </td><td align="left" valign="top" rowspan="1" colspan="1">Before+after</td><td align="center" valign="top" rowspan="1" colspan="1">0.231*</td><td align="center" valign="top" rowspan="1" colspan="1">0.026</td><td align="center" valign="top" rowspan="1" colspan="1">0.02</td><td align="center" valign="top" rowspan="1" colspan="1">0.049</td><td align="center" valign="top" rowspan="1" colspan="1">0.034</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Before</td><td align="center" valign="top" rowspan="1" colspan="1">0.249<sup>&#x02020;</sup></td><td align="center" valign="top" rowspan="1" colspan="1">0.052</td><td align="center" valign="top" rowspan="1" colspan="1">0.012</td><td align="center" valign="top" rowspan="1" colspan="1">0.139</td><td align="center" valign="top" rowspan="1" colspan="1">0.122</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">After</td><td align="center" valign="top" rowspan="1" colspan="1">0.271<sup>&#x02020;</sup></td><td align="center" valign="top" rowspan="1" colspan="1">0.002</td><td align="center" valign="top" rowspan="1" colspan="1">0.047</td><td align="center" valign="top" rowspan="1" colspan="1">0.047</td><td align="center" valign="top" rowspan="1" colspan="1">0.157</td></tr></tbody></table><table-wrap-foot><p>Analysis was based on data of blood parameters and the composition of fecal microbiota obtained at
before and/or after surgery of all patients. Blood parameters employed for before and after operation
were those obtained at D&#x02013;14 and D7, respectively. <sup>&#x02020;</sup>p&#x0003c;0.1,*p&#x0003c;0.05, **p&#x0003c;0.01,
***p&#x0003c;0.001, Spearman&#x02019;s correlation analysis.</p></table-wrap-foot></table-wrap>). The correlations associated with Actinobacteria were observed in samples collected both
preoperatively or postoperatively; however, the correlations associated with Proteobacteria were not observed
in samples collected preoperatively (<xref rid="tbl_004" ref-type="table">Table 4</xref>).</p></sec></sec><sec sec-type="discussion" id="s4"><title>DISCUSSION</title><p>Postoperative infections remain significant risk factors for patients undergoing surgery for cancers, such as
colorectal cancer and biliary cancer, and are often indicators of postoperative health and recovery. Zhang, Liu
and colleagues [<xref rid="r22" ref-type="bibr">22</xref>,<xref rid="r23" ref-type="bibr">23</xref>,<xref rid="r24" ref-type="bibr">24</xref>] evaluated the effects of administering perioperative probiotic
supplements containing <italic>L. plantarum, L. acidophilus,</italic> and <italic>B. longum</italic> to patients
undergoing colorectal resection. The probiotic group recovered postoperative peristalsis more rapidly,
accompanied by lower incidences of diarrhea and infectious-related complications [<xref rid="r22" ref-type="bibr">22</xref>].</p><p>In the present study, although the incidence of SSI was higher in the control group than in the probiotic
group, the difference was not significant. However, among the patients who received preoperative CRT, the
duration of postoperative hospital stay differed significantly between the two groups. CRT, which is usually
applied to patients with severe case, often disrupts the colonization of indigenous microbiota and subsequently
affects gut immunity [<xref rid="r25" ref-type="bibr">25</xref>, <xref rid="r26" ref-type="bibr">26</xref>]. We
observed a higher incidence of SSI in the CRT patients compared with those without CRT treatment (<xref rid="tbl_001" ref-type="table">Table 1</xref>). The patients in the control group also had increased levels of
hCRP and IL-6, accompanied by decreased levels of NK cell activity two weeks after surgery (<xref ref-type="fig" rid="fig_003">Fig. 3</xref>). High postoperative levels of CRP are associated with bacterial translocation and
prolonged hospitalization and are often critical indicators of post-operative infections [<xref rid="r22" ref-type="bibr">22</xref>]. Our results showed significantly earlier postoperative recovery of serum levels of hCRP
and NK cell activity in the probiotic group compared with the control group among CRT patients. This is in
agreement with previous reports that demonstrated the potential of <italic>B. longum</italic> BB536 in
suppressing inflammatory reactions and maintaining innate immune responses [<xref rid="r13" ref-type="bibr">13</xref>, <xref rid="r27" ref-type="bibr">27</xref>].</p><p>Surgery led to significant declines in the levels of erythrocytes, hemoglobin, total protein and albumin,
however, an improvement in postoperative recovery of hematological and nutritional parameters was observed in
the probiotic group. To our knowledge, this is the first report on the possible effects of perioperative
probiotic intervention on postoperative hematological and nutritional and parameters of patients undergoing
colectomy for cancer. The exact mechanisms of bifidobacteria in improving hematological and nutritional
parameters remain unclear. However, several possibilities have been suggested: (1) increased mineral solubility
through the production of short-chain fatty acids; (2) production of a phytase that reduces phytate as an
antinutrient that leads to mineral unavailability; (3) reducing inflammation, which negatively impacts mineral
uptake and nutritional status; and (4) hydrolysis of glycoside bonds of food in the intestines [<xref rid="r28" ref-type="bibr">28</xref>]. In addition, some bifidobacteria, including <italic>B. longum</italic>
BB536, have been reported to have a high potential for producing folate [<xref rid="r29" ref-type="bibr">29</xref>, <xref rid="r30" ref-type="bibr">30</xref>]. Folate is crucial for its roles in essential functions
of cell metabolism, such as DNA replication, repair, and methylation and synthesis of nucleotides, vitamins, and
some amino acids, and has been known to promote the generation of erythrocytes [<xref rid="r31" ref-type="bibr">31</xref>, <xref rid="r32" ref-type="bibr">32</xref>]. In addition, <italic>B. longum</italic> BB536 has also
been demonstrated to possess anti-inflammatory effects [<xref rid="r27" ref-type="bibr">27</xref>]. We postulate
that the improved postoperative nutritional status observed in the present study was attributed to the
anti-inflammatory effects and the production of folate and phytase in the intestine by <italic>B.
longum</italic> BB536. However, further study is needed to elucidate the details of these mechanisms.</p><p>Several studies have demonstrated the effects of perioperative probiotic supplementation on the
gastrointestinal microbiota [<xref rid="r5" ref-type="bibr">5</xref>, <xref rid="r6" ref-type="bibr">6</xref>,
<xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r22" ref-type="bibr">22</xref>]. We observed significant
changes at the phylum level in the fecal microbiota 1 to 2 weeks after surgery (<xref rid="tbl_003" ref-type="table">Table 3</xref>); Firmicutes increased in both groups, Proteobacteria and Bacteroidetes
increased in the control group but not in the probiotic group, and Actinobacteria increased in the probiotic
group but not in the control group. In addition, we found some feeble but significant correlations between the
proportions of the microbiota and blood parameters. The proportions of Proteobacteria and Bacteroidetes
positively correlated with the levels of inflammatory parameters (CRP, IL-6, and white blood cells), while the
proportions of Actinobacteria and Firmicutes tended to be negatively correlated with these parameters. All
patients received antibiotic prophylaxis (cefmetazole) as a single intravenous drip infusion on the days of
surgery and one day after surgery, which may be one of the causes of the microbiota changes. Considering the
physiological functions of each bacterial group, Proteobacteria are normally present at low levels in a healthy
gut environment but often overgrow in inflammatory states [<xref rid="r33" ref-type="bibr">33</xref>, <xref rid="r34" ref-type="bibr">34</xref>], leading to opportunistic infections. Biagi et al. [<xref rid="r35" ref-type="bibr">35</xref>] showed positive correlations between opportunistic enterobacteria and some
pro-inflammatory markers (IL-6 and IL-8). Contrarily, the genus <italic>Bifidobacterium</italic> is a bacterial
group known to downregulate the pro-inflammatory response of the gut epithelium [<xref rid="r36" ref-type="bibr">36</xref>, <xref rid="r37" ref-type="bibr">37</xref>]. These observations suggest a possible association
between the balance of the microbiota and systemic inflammatory response of the patients.</p><p>On the other hand, the current study showed that the proportion of Actinobacteria positively correlated with
the levels of erythrocytes, hemoglobin, albumin, and NK cell activity and that the proportion of Firmicutes
positively correlated with the levels of lymphocytes, total protein, and albumin; all these parameter tended to
be negatively correlated with the proportions of Proteobacteria and Bacteroidetes. As described above, the
anti-inflammatory effects and the metabolites generated in the intestine by bifidobacteria, the main components
of Actinobacteria, might have contributed to the improvement of the immune function, hematological, and
nutritional parameters of these patients. Several studies have demonstrated the effects of administration of
<italic>B. longum</italic> BB536 in maintaining balance and eliminating harmful bacteria [<xref rid="r38" ref-type="bibr">38</xref>,<xref rid="r39" ref-type="bibr">39</xref>,<xref rid="r40" ref-type="bibr">40</xref>]. Therefore, we think that probiotic ingestion contributed to the increased proportion of
Actinobacteria in the microbiota, which might have also influenced the proportions of other components of the
microbiota. Based on these findings, we conclude that maintaining the balance of the gut microbiota is important
for maintaining host defenses and nutritional status, especially during recovery from major surgery.</p><p>This study has several limitations. We were unable to perform a placebo-controlled trial due to ethical issues
in this hospital. Although the physicians who diagnosed infections were not directly involved in the
randomization, we could not exclude the possibility of bias in the clinical observation of the infectious
symptoms. However, administration of probiotics had objective effects on blood parameters and the composition of
the microbiota. Another limitation is that the number of subject might have been insufficient to detect possible
clinical significance, because of the low incidence of postoperative infection. We expected an incidence of 40%
of postoperative infectious complications in the control group, but it was much lower (approximately 31%).
Therefore, future large-scale randomized controlled trial (RCT) studies are needed to confirm the health
benefits of the ingestion of <italic>B. longum</italic> BB536 for patients with unbalanced health
conditions.</p><p>In conclusion, this study shows the potential of the <italic>B. longum</italic> BB536 intervention in balancing
the postoperative intestinal microbiota, attenuating systemic postoperative inflammatory responses, and
improving recovery of hematological and nutritional conditions in patients undergoing colorectal surgery. These
beneficial effects are likely to reduce the risk of postoperative infectious complications and to promote
healthy recovery after colorectal resection. Our findings suggest that the administration of <italic>B.
longum</italic> BB536 may represent an effective strategy to maintain a balance in the microbiota and promote
healthy recovery in patients undergoing surgery.</p></sec></body><back><ack><p>The authors thank Dr. Liong MT at School of Industrial Technology, Universiti Sains Malaysia, for her critical
check of this manuscript.</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><mixed-citation publication-type="eref">Food and Agriculture Organization of the United
Nations and World Health Organization. Health and nutritional properties of probiotics in food including
powder milk with live lactic acid bacteria. Report of a Joint FAO/WHO Expert Consultation on Evaluation of
Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid,
<year>2001</year> Bacteria. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.fao.org/es/ESN/food/food_probio_en.stm">http://www.fao.org/es/ESN/food/food_probio_en.stm</ext-link>.</mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group><name><surname>Madsen</surname><given-names>K</given-names></name><name><surname>Cornish</surname><given-names>A</given-names></name><name><surname>Soper</surname><given-names>P</given-names></name><name><surname>McKaigney</surname><given-names>C</given-names></name><name><surname>Jijon</surname><given-names>H</given-names></name><name><surname>Yachimec</surname><given-names>C</given-names></name><name><surname>Doyle</surname><given-names>J</given-names></name><name><surname>Jewell</surname><given-names>L</given-names></name><name><surname>De Simone</surname><given-names>C</given-names></name></person-group>
<year>2001</year>
<article-title>Probiotic bacteria enhance murine and human intestinal
epithelial barrier function</article-title>. <source>Gastroenterology</source><volume> 121</volume>:
<fpage>580</fpage>&#x02013;<lpage>591</lpage>. <pub-id pub-id-type="pmid">11522742</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group><name><surname>Macfarlane</surname><given-names>GT</given-names></name><name><surname>Cummings</surname><given-names>JH</given-names></name></person-group>
<year>2002</year>
<article-title>Probiotics, infection and immunity</article-title>.
<source>Curr Opin Infect Dis</source><volume> 15</volume>: <fpage>501</fpage>&#x02013;<lpage>506</lpage>.
<pub-id pub-id-type="pmid">12686883</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group><name><surname>Rayes</surname><given-names>N</given-names></name><name><surname>Seehofer</surname><given-names>D</given-names></name><name><surname>Hansen</surname><given-names>S</given-names></name><name><surname>Boucsein</surname><given-names>K</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>AR</given-names></name><name><surname>Serke</surname><given-names>S</given-names></name><name><surname>Bengmark</surname><given-names>S</given-names></name><name><surname>Neuhaus</surname><given-names>P</given-names></name></person-group>
<year>2002</year>
<article-title>Early enteral supply of lactobacillus and fiber versus
selective bowel decontamination: a controlled trial in liver transplant recipients</article-title>.
<source>Transplantation</source><volume> 74</volume>: <fpage>123</fpage>&#x02013;<lpage>127</lpage>.
<pub-id pub-id-type="pmid">12134110</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group><name><surname>Kanazawa</surname><given-names>H</given-names></name><name><surname>Nagino</surname><given-names>M</given-names></name><name><surname>Kamiya</surname><given-names>S</given-names></name><name><surname>Komatsu</surname><given-names>S</given-names></name><name><surname>Mayumi</surname><given-names>T</given-names></name><name><surname>Takagi</surname><given-names>K</given-names></name><name><surname>Asahara</surname><given-names>T</given-names></name><name><surname>Nomoto</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>R</given-names></name><name><surname>Nimura</surname><given-names>Y</given-names></name></person-group>
<year>2005</year>
<article-title>Synbiotics reduce postoperative infectious complications: a
randomized controlled trial in biliary cancer patients undergoing hepatectomy</article-title>.
<source>Langenbecks Arch Surg</source><volume> 390</volume>: <fpage>104</fpage>&#x02013;<lpage>113</lpage>.
<pub-id pub-id-type="pmid">15711820</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group><name><surname>Sugawara</surname><given-names>G</given-names></name><name><surname>Nagino</surname><given-names>M</given-names></name><name><surname>Nishio</surname><given-names>H</given-names></name><name><surname>Ebata</surname><given-names>T</given-names></name><name><surname>Takagi</surname><given-names>K</given-names></name><name><surname>Asahara</surname><given-names>T</given-names></name><name><surname>Nomoto</surname><given-names>K</given-names></name><name><surname>Nimura</surname><given-names>Y</given-names></name></person-group>
<year>2006</year>
<article-title>Perioperative synbiotic treatment to prevent postoperative
infectious complications in biliary cancer surgery: a randomized controlled trial</article-title>.
<source>Ann Surg</source><volume> 244</volume>: <fpage>706</fpage>&#x02013;<lpage>714</lpage>. <pub-id pub-id-type="pmid">17060763</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group><name><surname>Nomura</surname><given-names>T</given-names></name><name><surname>Tsuchiya</surname><given-names>Y</given-names></name><name><surname>Nashimoto</surname><given-names>A</given-names></name><name><surname>Yabusaki</surname><given-names>H</given-names></name><name><surname>Takii</surname><given-names>Y</given-names></name><name><surname>Nakagawa</surname><given-names>S</given-names></name><name><surname>Sato</surname><given-names>N</given-names></name><name><surname>Kanbayashi</surname><given-names>C</given-names></name><name><surname>Tanaka</surname><given-names>O</given-names></name></person-group>
<year>2007</year>
<article-title>Probiotics reduce infectious complications after
pancreaticoduodenectomy</article-title>. <source>Hepatogastroenterology</source><volume> 54</volume>:
<fpage>661</fpage>&#x02013;<lpage>663</lpage>. <pub-id pub-id-type="pmid">17591036</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group><name><surname>Okazaki</surname><given-names>M</given-names></name><name><surname>Matsukuma</surname><given-names>S</given-names></name><name><surname>Suto</surname><given-names>R</given-names></name><name><surname>Miyazaki</surname><given-names>K</given-names></name><name><surname>Hidaka</surname><given-names>M</given-names></name><name><surname>Matsuo</surname><given-names>M</given-names></name><name><surname>Noshima</surname><given-names>S</given-names></name><name><surname>Zempo</surname><given-names>N</given-names></name><name><surname>Asahara</surname><given-names>T</given-names></name><name><surname>Nomoto</surname><given-names>K</given-names></name></person-group>
<year>2013</year>
<article-title>Perioperative synbiotic therapy in elderly patients
undergoing gastroenterological surgery: a prospective, randomized control trial</article-title>.
<source>Nutrition</source><volume> 29</volume>: <fpage>1224</fpage>&#x02013;<lpage>1230</lpage>. <pub-id pub-id-type="pmid">23867209</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group><name><surname>Peitsidou</surname><given-names>K</given-names></name><name><surname>Karantanos</surname><given-names>T</given-names></name><name><surname>Theodoropoulos</surname><given-names>GE</given-names></name></person-group>
<year>2012</year>
<article-title>Probiotics, prebiotics, synbiotics: is there enough
evidence to support their use in colorectal cancer surgery?</article-title><source>Dig Surg</source><volume>
29</volume>: <fpage>426</fpage>&#x02013;<lpage>438</lpage>. <pub-id pub-id-type="pmid">23258276</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group><name><surname>He</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>HY</given-names></name><name><surname>Feng</surname><given-names>JY</given-names></name><name><surname>Zhang</surname><given-names>MM</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>XT</given-names></name></person-group>
<year>2013</year>
<article-title>Use of pro-/synbiotics as prophylaxis in patients
undergoing colorectal resection for cancer: a meta-analysis of randomized controlled trials</article-title>.
<source>Clin Res Hepatol Gastroenterol</source><volume> 37</volume>: <fpage>406</fpage>&#x02013;<lpage>415</lpage>.
<pub-id pub-id-type="pmid">23182673</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group><name><surname>Jeppsson</surname><given-names>B</given-names></name><name><surname>Mangell</surname><given-names>P</given-names></name><name><surname>Thorlacius</surname><given-names>H</given-names></name></person-group>
<year>2011</year>
<article-title>Use of probiotics as prophylaxis for postoperative
infections</article-title>. <source>Nutrients</source><volume> 3</volume>:
<fpage>604</fpage>&#x02013;<lpage>612</lpage>. <pub-id pub-id-type="pmid">22254113</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="book"><person-group><name><surname>Xiao</surname><given-names>JZ</given-names></name></person-group> Bifidobacterium longum BB536. In: Lee KL, Salminen S (eds). <year>2009</year>. Hanbook of
Probiotics and Prebiotics, 2nd ed. John Wiley &#x00026; Sons, New Jersey, pp. 488&#x02013;491.</mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group><name><surname>Akatsu</surname><given-names>H</given-names></name><name><surname>Iwabuchi</surname><given-names>N</given-names></name><name><surname>Xiao</surname><given-names>JZ</given-names></name><name><surname>Matsuyama</surname><given-names>Z</given-names></name><name><surname>Kurihara</surname><given-names>R</given-names></name><name><surname>Okuda</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Maruyama</surname><given-names>M</given-names></name></person-group>
<year>2013</year>
<article-title>Clinical effects of probiotic <italic>Bifidobacterium
longum</italic> BB536 on immune function and intestinal microbiota in elderly patients receiving enteral
tube feeding</article-title>. <source>JPEN J Parenter Enteral Nutr</source><volume> 37</volume>:
<fpage>631</fpage>&#x02013;<lpage>640</lpage>. <pub-id pub-id-type="pmid">23192454</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group><name><surname>Mangram</surname><given-names>AJ</given-names></name><name><surname>Horan</surname><given-names>TC</given-names></name><name><surname>Pearson</surname><given-names>ML</given-names></name><name><surname>Silver</surname><given-names>LC</given-names></name><name><surname>Jarvis</surname><given-names>WR</given-names></name></person-group>, Hospital Infection Control Practices Advisory Committee. <year>1999</year>
<article-title>Guideline for prevention of surgical site infection, 1999</article-title>. <source>Infect
Control Hosp Epidemiol</source><volume> 20</volume>: <fpage>250</fpage>&#x02013;<lpage>278, quiz 279&#x02013;280</lpage>.
<pub-id pub-id-type="pmid">10219875</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group><name><surname>Namba</surname><given-names>K</given-names></name><name><surname>Hatano</surname><given-names>M</given-names></name><name><surname>Yaeshima</surname><given-names>T</given-names></name><name><surname>Takase</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name></person-group>
<year>2010</year>
<article-title>Effects of <italic>Bifidobacterium longum</italic> BB536
administration on influenza infection, influenza vaccine antibody titer, and cell-mediated immunity in the
elderly</article-title>. <source>Biosci Biotechnol Biochem</source><volume> 74</volume>:
<fpage>939</fpage>&#x02013;<lpage>945</lpage>. <pub-id pub-id-type="pmid">20460726</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group><name><surname>Odamaki</surname><given-names>T</given-names></name><name><surname>Xiao</surname><given-names>JZ</given-names></name><name><surname>Iwabuchi</surname><given-names>N</given-names></name><name><surname>Sakamoto</surname><given-names>M</given-names></name><name><surname>Takahashi</surname><given-names>N</given-names></name><name><surname>Kondo</surname><given-names>S</given-names></name><name><surname>Miyaji</surname><given-names>K</given-names></name><name><surname>Iwatsuki</surname><given-names>K</given-names></name><name><surname>Togashi</surname><given-names>H</given-names></name><name><surname>Enomoto</surname><given-names>T</given-names></name><name><surname>Benno</surname><given-names>Y</given-names></name></person-group>
<year>2007</year>
<article-title>Influence of <italic>Bifidobacterium longum</italic> BB536
intake on faecal microbiota in individuals with Japanese cedar pollinosis during the pollen
season</article-title>. <source>J Med Microbiol</source><volume> 56</volume>:
<fpage>1301</fpage>&#x02013;<lpage>1308</lpage>. <pub-id pub-id-type="pmid">17893165</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group><name><surname>Aronesty</surname><given-names>E</given-names></name></person-group>
<year>2013</year>
<article-title>Comparison of sequencing utility programs</article-title>.
<source>Open Bioinforma J</source><volume> 7</volume>: <fpage>1</fpage>&#x02013;<lpage>8</lpage>. </mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group><name><surname>Caporaso</surname><given-names>JG</given-names></name><name><surname>Kuczynski</surname><given-names>J</given-names></name><name><surname>Stombaugh</surname><given-names>J</given-names></name><name><surname>Bittinger</surname><given-names>K</given-names></name><name><surname>Bushman</surname><given-names>FD</given-names></name><name><surname>Costello</surname><given-names>EK</given-names></name><name><surname>Fierer</surname><given-names>N</given-names></name><name><surname>Pe&#x000f1;a</surname><given-names>AG</given-names></name><name><surname>Goodrich</surname><given-names>JK</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name><name><surname>Huttley</surname><given-names>GA</given-names></name><name><surname>Kelley</surname><given-names>ST</given-names></name><name><surname>Knights</surname><given-names>D</given-names></name><name><surname>Koenig</surname><given-names>JE</given-names></name><name><surname>Ley</surname><given-names>RE</given-names></name><name><surname>Lozupone</surname><given-names>CA</given-names></name><name><surname>McDonald</surname><given-names>D</given-names></name><name><surname>Muegge</surname><given-names>BD</given-names></name><name><surname>Pirrung</surname><given-names>M</given-names></name><name><surname>Reeder</surname><given-names>J</given-names></name><name><surname>Sevinsky</surname><given-names>JR</given-names></name><name><surname>Turnbaugh</surname><given-names>PJ</given-names></name><name><surname>Walters</surname><given-names>WA</given-names></name><name><surname>Widmann</surname><given-names>J</given-names></name><name><surname>Yatsunenko</surname><given-names>T</given-names></name><name><surname>Zaneveld</surname><given-names>J</given-names></name><name><surname>Knight</surname><given-names>R</given-names></name></person-group>
<year>2010</year>
<article-title>QIIME allows analysis of high-throughput community
sequencing data</article-title>. <source>Nat Methods</source><volume> 7</volume>:
<fpage>335</fpage>&#x02013;<lpage>336</lpage>. <pub-id pub-id-type="pmid">20383131</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="book"><person-group><name><surname>Kuczynski</surname><given-names>J</given-names></name><name><surname>Stombaugh</surname><given-names>J</given-names></name><name><surname>Walters</surname><given-names>WA</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>A</given-names></name><name><surname>Caporaso</surname><given-names>JG</given-names></name><name><surname>Knight</surname><given-names>R</given-names></name></person-group>
<year>2011</year>. Using QIIME to analyze 16S rRNA gene sequences from microbial communities.
Current Protocols in Bioinformatics Chapter 10: Unit 10.7.</mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group><name><surname>Edgar</surname><given-names>RC</given-names></name><name><surname>Haas</surname><given-names>BJ</given-names></name><name><surname>Clemente</surname><given-names>JC</given-names></name><name><surname>Quince</surname><given-names>C</given-names></name><name><surname>Knight</surname><given-names>R</given-names></name></person-group>
<year>2011</year>
<article-title>UCHIME improves sensitivity and speed of chimera
detection</article-title>. <source>Bioinformatics</source><volume> 27</volume>:
<fpage>2194</fpage>&#x02013;<lpage>2200</lpage>. <pub-id pub-id-type="pmid">21700674</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group><name><surname>McDonald</surname><given-names>D</given-names></name><name><surname>Price</surname><given-names>MN</given-names></name><name><surname>Goodrich</surname><given-names>J</given-names></name><name><surname>Nawrocki</surname><given-names>EP</given-names></name><name><surname>DeSantis</surname><given-names>TZ</given-names></name><name><surname>Probst</surname><given-names>A</given-names></name><name><surname>Andersen</surname><given-names>GL</given-names></name><name><surname>Knight</surname><given-names>R</given-names></name><name><surname>Hugenholtz</surname><given-names>P</given-names></name></person-group>
<year>2012</year>
<article-title>An improved Greengenes taxonomy with explicit ranks for
ecological and evolutionary analyses of bacteria and archaea</article-title>. <source>ISME
J</source><volume> 6</volume>: <fpage>610</fpage>&#x02013;<lpage>618</lpage>. <pub-id pub-id-type="pmid">22134646</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Qin</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>Q</given-names></name></person-group>
<year>2011</year>
<article-title>Randomised clinical trial: the effects of perioperative
probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer
surgery &#x02014;a double-blind study</article-title>. <source>Aliment Pharmacol Ther</source><volume> 33</volume>:
<fpage>50</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="pmid">21083585</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group><name><surname>Zhang</surname><given-names>JW</given-names></name><name><surname>Du</surname><given-names>P</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>BR</given-names></name><name><surname>Fang</surname><given-names>WJ</given-names></name><name><surname>Ying</surname><given-names>CM</given-names></name></person-group>
<year>2012</year>
<article-title>Preoperative probiotics decrease postoperative infectious
complications of colorectal cancer</article-title>. <source>Am J Med Sci</source><volume> 343</volume>:
<fpage>199</fpage>&#x02013;<lpage>205</lpage>. <pub-id pub-id-type="pmid">22197980</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group><name><surname>Liu</surname><given-names>ZH</given-names></name><name><surname>Huang</surname><given-names>MJ</given-names></name><name><surname>Zhang</surname><given-names>XW</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>NQ</given-names></name><name><surname>Peng</surname><given-names>H</given-names></name><name><surname>Lan</surname><given-names>P</given-names></name><name><surname>Peng</surname><given-names>JS</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>WJ</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Qin</surname><given-names>HL</given-names></name><name><surname>Wang</surname><given-names>JP</given-names></name></person-group>
<year>2013</year>
<article-title>The effects of perioperative probiotic treatment on serum
zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery:
a double-center and double-blind randomized clinical trial</article-title>. <source>Am J Clin
Nutr</source><volume> 97</volume>: <fpage>117</fpage>&#x02013;<lpage>126</lpage>. <pub-id pub-id-type="pmid">23235200</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Teng</surname><given-names>F</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Yuan</surname><given-names>X</given-names></name><name><surname>Zeng</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name></person-group>
<year>2014</year>
<article-title>Changes of saliva microbiota in nasopharyngeal carcinoma
patients under chemoradiation therapy</article-title>. <source>Arch Oral Biol</source><volume> 59</volume>:
<fpage>176</fpage>&#x02013;<lpage>186</lpage>. <pub-id pub-id-type="pmid">24370189</pub-id></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group><name><surname>Fraunholz</surname><given-names>IB</given-names></name><name><surname>Haberl</surname><given-names>A</given-names></name><name><surname>Klauke</surname><given-names>S</given-names></name><name><surname>Gute</surname><given-names>P</given-names></name><name><surname>R&#x000f6;del</surname><given-names>CM</given-names></name></person-group>
<year>2014</year>
<article-title>Long-term effects of chemoradiotherapy for anal cancer in
patients with HIV infection: oncological outcomes, immunological status, and the clinical course of the HIV
disease</article-title>. <source>Dis Colon Rectum</source><volume> 57</volume>:
<fpage>423</fpage>&#x02013;<lpage>431</lpage>. <pub-id pub-id-type="pmid">24608297</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group><name><surname>Tomosada</surname><given-names>Y</given-names></name><name><surname>Villena</surname><given-names>J</given-names></name><name><surname>Murata</surname><given-names>K</given-names></name><name><surname>Chiba</surname><given-names>E</given-names></name><name><surname>Shimazu</surname><given-names>T</given-names></name><name><surname>Aso</surname><given-names>H</given-names></name><name><surname>Iwabuchi</surname><given-names>N</given-names></name><name><surname>Xiao</surname><given-names>JZ</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name><name><surname>Kitazawa</surname><given-names>H</given-names></name></person-group>
<year>2013</year>
<article-title>Immunoregulatory effect of bifidobacteria strains in
porcine intestinal epithelial cells through modulation of ubiquitin-editing enzyme A20
expression</article-title>. <source>PLoS ONE</source><volume> 8</volume>: <fpage>e59259</fpage>.
<pub-id pub-id-type="pmid">23555642</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group><name><surname>Parvaneh</surname><given-names>K</given-names></name><name><surname>Jamaluddin</surname><given-names>R</given-names></name><name><surname>Karimi</surname><given-names>G</given-names></name><name><surname>Erfani</surname><given-names>R</given-names></name></person-group>
<year>2014</year>
<article-title>Effect of probiotics supplementation on bone mineral
content and bone mass density</article-title>. <source>Scientific World Journal</source><volume>
2014</volume>: <fpage>595962</fpage>. <pub-id pub-id-type="pmid">24587733</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group><name><surname>Deguchi</surname><given-names>Y</given-names></name><name><surname>Morishita</surname><given-names>T</given-names></name><name><surname>Mutai</surname><given-names>M</given-names></name></person-group>
<year>1985</year>
<article-title>Comparative studies on synthesis of water-soluble vitamins
among human species of bifidobacteria</article-title>. <source>Agric Biol Chern</source><volume>
49</volume>: <fpage>13</fpage>&#x02013;<lpage>19</lpage>. </mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group><name><surname>Sugahara</surname><given-names>H</given-names></name><name><surname>Odamaki</surname><given-names>T</given-names></name><name><surname>Hashikura</surname><given-names>N</given-names></name><name><surname>Abe</surname><given-names>F</given-names></name><name><surname>Xiao</surname><given-names>JZ</given-names></name></person-group>
<year>2015</year>
<article-title>Differences in folate production by bifidobacteria of
different origins</article-title>. <source>Biosci Microbiota Food Health</source><volume> 34</volume>:
<fpage>87</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="pmid">26594608</pub-id></mixed-citation></ref><ref id="r31"><label>31</label><mixed-citation publication-type="journal"><person-group><name><surname>Iyer</surname><given-names>R</given-names></name><name><surname>Tomar</surname><given-names>SK</given-names></name></person-group>
<year>2009</year>
<article-title>Folate: a functional food constituent</article-title>.
<source>J Food Sci</source><volume> 74</volume>: <fpage>R114</fpage>&#x02013;<lpage>R122</lpage>. <pub-id pub-id-type="pmid">20492126</pub-id></mixed-citation></ref><ref id="r32"><label>32</label><mixed-citation publication-type="journal"><person-group><name><surname>LeBlanc</surname><given-names>JG</given-names></name><name><surname>Lai&#x000f1;o</surname><given-names>JE</given-names></name><name><surname>del Valle</surname><given-names>MJ</given-names></name><name><surname>Vannini</surname><given-names>V</given-names></name><name><surname>van Sinderen</surname><given-names>D</given-names></name><name><surname>Taranto</surname><given-names>MP</given-names></name><name><surname>de Valdez</surname><given-names>GF</given-names></name><name><surname>de Giori</surname><given-names>GS</given-names></name><name><surname>Sesma</surname><given-names>F</given-names></name></person-group>
<year>2011</year>
<article-title>B-group vitamin production by lactic acid bacteria&#x02014;current
knowledge and potential applications</article-title>. <source>J Appl Microbiol</source><volume>
111</volume>: <fpage>1297</fpage>&#x02013;<lpage>1309</lpage>. <pub-id pub-id-type="pmid">21933312</pub-id></mixed-citation></ref><ref id="r33"><label>33</label><mixed-citation publication-type="journal"><person-group><name><surname>P&#x000e9;dron</surname><given-names>T</given-names></name><name><surname>Sansonetti</surname><given-names>P</given-names></name></person-group>
<year>2008</year>
<article-title>Commensals, bacterial pathogens and intestinal
inflammation: an intriguing m&#x000e9;nage &#x000e0; trois</article-title>. <source>Cell Host Microbe</source><volume>
3</volume>: <fpage>344</fpage>&#x02013;<lpage>347</lpage>. <pub-id pub-id-type="pmid">18541210</pub-id></mixed-citation></ref><ref id="r34"><label>34</label><mixed-citation publication-type="journal"><person-group><name><surname>Sansonetti</surname><given-names>PJ</given-names></name></person-group>
<year>2011</year>
<article-title>To be or not to be a pathogen: that is the mucosally
relevant question</article-title>. <source>Mucosal Immunol</source><volume> 4</volume>:
<fpage>8</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="pmid">21150896</pub-id></mixed-citation></ref><ref id="r35"><label>35</label><mixed-citation publication-type="journal"><person-group><name><surname>Biagi</surname><given-names>E</given-names></name><name><surname>Nylund</surname><given-names>L</given-names></name><name><surname>Candela</surname><given-names>M</given-names></name><name><surname>Ostan</surname><given-names>R</given-names></name><name><surname>Bucci</surname><given-names>L</given-names></name><name><surname>Pini</surname><given-names>E</given-names></name><name><surname>Nikk&#x000ef;la</surname><given-names>J</given-names></name><name><surname>Monti</surname><given-names>D</given-names></name><name><surname>Satokari</surname><given-names>R</given-names></name><name><surname>Franceschi</surname><given-names>C</given-names></name><name><surname>Brigidi</surname><given-names>P</given-names></name><name><surname>De Vos</surname><given-names>W</given-names></name></person-group>
<year>2010</year>
<article-title>Through ageing, and beyond: gut microbiota and inflammatory
status in seniors and centenarians</article-title>. <source>PLoS ONE</source><volume> 5</volume>:
<fpage>e10667</fpage>. <pub-id pub-id-type="pmid">20498852</pub-id></mixed-citation></ref><ref id="r36"><label>36</label><mixed-citation publication-type="journal"><person-group><name><surname>Groeger</surname><given-names>D</given-names></name><name><surname>O&#x02019;Mahony</surname><given-names>L</given-names></name><name><surname>Murphy</surname><given-names>EF</given-names></name><name><surname>Bourke</surname><given-names>JF</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Kiely</surname><given-names>B</given-names></name><name><surname>Shanahan</surname><given-names>F</given-names></name><name><surname>Quigley</surname><given-names>EM</given-names></name></person-group>
<year>2013</year>
<article-title><italic>Bifidobacterium infantis</italic> 35624 modulates
host inflammatory processes beyond the gut</article-title>. <source>Gut Microbes</source><volume>
4</volume>: <fpage>325</fpage>&#x02013;<lpage>339</lpage>. <pub-id pub-id-type="pmid">23842110</pub-id></mixed-citation></ref><ref id="r37"><label>37</label><mixed-citation publication-type="journal"><person-group><name><surname>Sagar</surname><given-names>S</given-names></name><name><surname>Morgan</surname><given-names>ME</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Vos</surname><given-names>AP</given-names></name><name><surname>Garssen</surname><given-names>J</given-names></name><name><surname>van Bergenhenegouwen</surname><given-names>J</given-names></name><name><surname>Boon</surname><given-names>L</given-names></name><name><surname>Georgiou</surname><given-names>NA</given-names></name><name><surname>Kraneveld</surname><given-names>AD</given-names></name><name><surname>Folkerts</surname><given-names>G</given-names></name></person-group>
<year>2014</year>
<article-title><italic>Bifidobacterium breve</italic> and
<italic>Lactobacillus rhamnosus</italic> treatment is as effective as budesonide at reducing inflammation
in a murine model for chronic asthma</article-title>. <source>Respir Res</source><volume> 15</volume>:
<fpage>46</fpage>. <pub-id pub-id-type="pmid">24735374</pub-id></mixed-citation></ref><ref id="r38"><label>38</label><mixed-citation publication-type="journal"><person-group><name><surname>Ogata</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name><name><surname>Fukuwatari</surname><given-names>Y</given-names></name><name><surname>Ishibashi</surname><given-names>N</given-names></name><name><surname>Fujisawa</surname><given-names>T</given-names></name><name><surname>Iino</surname><given-names>H</given-names></name></person-group>
<year>1997</year>
<article-title>Effect of <italic>Bifidobacterium longum</italic> BB536
administration on the intestinal environment, defecation frequency and fecal characteristics of human
volunteers</article-title>. <source>Bioscience Microflora</source><volume> 16</volume>:
<fpage>53</fpage>&#x02013;<lpage>58</lpage>. </mixed-citation></ref><ref id="r39"><label>39</label><mixed-citation publication-type="journal"><person-group><name><surname>Yaeshima</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name><name><surname>Matsumoto</surname><given-names>N</given-names></name><name><surname>Ishibashi</surname><given-names>N</given-names></name><name><surname>Hayasawa</surname><given-names>H</given-names></name><name><surname>Iino</surname><given-names>H</given-names></name></person-group>
<year>1997</year>
<article-title>Effect of yogurt containing <italic>Bifidobacterium
longum</italic> BB536 on the intestinal environment, fecal characteristics and defecation frequency: a
comparison with standard yogurt</article-title>. <source>Bioscience Microflora</source><volume> 16</volume>:
<fpage>73</fpage>&#x02013;<lpage>77</lpage>. </mixed-citation></ref><ref id="r40"><label>40</label><mixed-citation publication-type="journal"><person-group><name><surname>Odamaki</surname><given-names>T</given-names></name><name><surname>Sugahara</surname><given-names>H</given-names></name><name><surname>Yonezawa</surname><given-names>S</given-names></name><name><surname>Yaeshima</surname><given-names>T</given-names></name><name><surname>Iwatsuki</surname><given-names>K</given-names></name><name><surname>Tanabe</surname><given-names>S</given-names></name><name><surname>Tominaga</surname><given-names>T</given-names></name><name><surname>Togashi</surname><given-names>H</given-names></name><name><surname>Benno</surname><given-names>Y</given-names></name><name><surname>Xiao</surname><given-names>JZ</given-names></name></person-group>
<year>2012</year>
<article-title>Effect of the oral intake of yogurt containing
<italic>Bifidobacterium longum</italic> BB536 on the cell numbers of enterotoxigenic <italic>Bacteroides
fragilis</italic> in microbiota</article-title>. <source>Anaerobe</source><volume> 18</volume>:
<fpage>14</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="pmid">22138361</pub-id></mixed-citation></ref></ref-list></back></article>